$ARVN stock has now risen 14% today, according to our price data from Polygon. There has been approximately $45,245,389 of trading volume.
Here is what we see in our data on $ARVN (you can track the company live on Quiver's $ARVN stock page):
$ARVN Insider Trading Activity
$ARVN insiders have traded $ARVN stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ARVN stock by insiders over the last 6 months:
- BRIGGS MORRISON purchased 30,000 shares for an estimated $227,010
- ANDREW SAIK (Chief Financial Officer) sold 5,700 shares for an estimated $43,377
- ANGELA M CACACE (Chief Scientific Officer) sold 2,583 shares for an estimated $19,346
- DAVID K LOOMIS (Chief Accounting Officer) sold 230 shares for an estimated $2,274
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARVN Hedge Fund Activity
We have seen 106 institutional investors add shares of $ARVN stock to their portfolio, and 142 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 3,522,849 shares (-95.9%) from their portfolio in Q3 2025, for an estimated $30,014,673
- RTW INVESTMENTS, LP removed 3,334,308 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $24,540,506
- LOGOS GLOBAL MANAGEMENT LP added 2,275,000 shares (+68.9%) to their portfolio in Q3 2025, for an estimated $19,383,000
- ALYESKA INVESTMENT GROUP, L.P. removed 1,800,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $13,248,000
- TCG CROSSOVER MANAGEMENT, LLC added 1,617,365 shares (+inf%) to their portfolio in Q3 2025, for an estimated $13,779,949
- CAPTION MANAGEMENT, LLC removed 1,343,029 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,442,607
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,246,656 shares (-93.5%) from their portfolio in Q3 2025, for an estimated $10,621,509
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ARVN Analyst Ratings
Wall Street analysts have issued reports on $ARVN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 11/10/2025
- BTIG issued a "Buy" rating on 09/18/2025
- Guggenheim issued a "Buy" rating on 08/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/07/2025
- Wells Fargo issued a "Overweight" rating on 08/07/2025
To track analyst ratings and price targets for $ARVN, check out Quiver Quantitative's $ARVN forecast page.
$ARVN Price Targets
Multiple analysts have issued price targets for $ARVN recently. We have seen 8 analysts offer price targets for $ARVN in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Sudan Loganathan from Stephens & Co. set a target price of $15.0 on 11/10/2025
- Derek Archila from Wells Fargo set a target price of $15.0 on 11/06/2025
- Etzer Darout from Barclays set a target price of $16.0 on 11/06/2025
- Jeet Mukherjee from BTIG set a target price of $14.0 on 10/30/2025
- Paul Choi from Goldman Sachs set a target price of $6.0 on 10/15/2025
- Michael Schmidt from Guggenheim set a target price of $15.0 on 08/07/2025
- Andrew S. Fein from HC Wainwright & Co. set a target price of $18.0 on 08/07/2025
You can track data on $ARVN on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
